Literature DB >> 24342647

Retrospective analysis of the efficacies of two different regimens of aqueous penicillin G administered to children with pneumonia.

Alyson Brandão1, Raquel Simbalista, Igor C Borges, Dafne C Andrade, Marcelo Araújo, Cristiana M Nascimento-Carvalho.   

Abstract

Community-acquired pneumonia (CAP) is an important childhood health problem. Penicillin remains appropriate for treating children with CAP. Clinical data are lacking on disease evolution in children treated with different posologic schemes of aqueous penicillin G. To assess if there were differences in disease evolution between children with CAP treated with 6 or 4 daily doses of aqueous penicillin G, we reviewed the medical charts of hospitalized patients 2 months to 11.5 years of age. Pneumonia was radiologically confirmed based on the detection of pulmonary infiltrate or pleural effusion on the chest radiograph taken on admission and read by a pediatric radiologist blinded to the clinical data. The total daily dose of aqueous penicillin G was 200,000 IU/kg of body weight. Data were recorded on admission, during disease evolution up to the 7th day of treatment, and at the final outcome. The results of hospitalization and the daily frequency of physical signs suggestive of pneumonia were assessed. The subgroups comprised 120 and 144 children who received aqueous penicillin G in 6 or 4 daily doses, respectively. Children≥5 years of age were more frequent in the 4-daily-doses subgroup (16.0% versus 4.2%; respectively, P=0.02). There were no differences between the compared subgroups in terms of final outcomes, lengths of hospitalization, durations of aqueous penicillin G use, frequencies of aqueous penicillin G substitution, or daily frequencies of tachypnea, fever, chest retraction, lower chest recession, nasal flaring, and cyanosis up to the 7th day of treatment. The studied posologic regimens were similarly effective in treating children hospitalized with a radiologically confirmed CAP diagnosis. Aqueous penicillin G (200,000 IU/kg/day) may be given in 4 daily doses to children with CAP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24342647      PMCID: PMC3957887          DOI: 10.1128/AAC.01951-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Physical signs in children with pneumonia.

Authors:  C M Nascimento-Carvalho
Journal:  Indian Pediatr       Date:  2001-03       Impact factor: 1.411

2.  Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies.

Authors:  Thomas Cherian; E Kim Mulholland; John B Carlin; Harald Ostensen; Ruhul Amin; Margaret de Campo; David Greenberg; Rosanna Lagos; Marilla Lucero; Shabir A Madhi; Katherine L O'Brien; Steven Obaro; Mark C Steinhoff
Journal:  Bull World Health Organ       Date:  2005-06-24       Impact factor: 9.408

Review 3.  Thermometry in paediatric practice.

Authors:  A S El-Radhi; W Barry
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

4.  Etiology of childhood community acquired pneumonia and its implications for vaccination.

Authors:  C M Nascimento-Carvalho
Journal:  Braz J Infect Dis       Date:  2001-08-03       Impact factor: 1.949

Review 5.  Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.

Authors:  M R Jacobs
Journal:  Am J Med       Date:  1999-05-03       Impact factor: 4.965

6.  Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.

Authors:  C Ponte; A Parra; E Nieto; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

7.  Ampicillin and penicillin concentration in serum and pleural fluid of hospitalized children with community-acquired pneumonia.

Authors:  Gustavo Giachetto; María Catalina Pirez; Luciana Nanni; Adriana Martínez; Alicia Montano; Gabriela Algorta; Sheldon L Kaplan; Ana María Ferrari
Journal:  Pediatr Infect Dis J       Date:  2004-07       Impact factor: 2.129

8.  [Parapneumonic pleural effusion: an 11-year review].

Authors:  L Deiros Bronte; F Baquero-Artigao; María J García-Miguel; N Hernández González; P Peña García; F del Castillo Martín
Journal:  An Pediatr (Barc)       Date:  2006-01       Impact factor: 1.500

Review 9.  [Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].

Authors:  José María Aguado-García; José Emilio Martín-Herrero; Carlos Lumbreras-Bermejo
Journal:  Enferm Infecc Microbiol Clin       Date:  2004-04       Impact factor: 1.731

10.  Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia.

Authors:  Maria Regina A Cardoso; Cristiana M Nascimento-Carvalho; Fernando Ferrero; Eitan N Berezin; Raúl Ruvinsky; Paulo A M Camargos; Clemax C Sant'anna; Maria Cristina C Brandileone; Maria de Fátima P March; Jesus Feris-Iglesias; Ruben S Maggi; Yehuda Benguigui
Journal:  Arch Dis Child       Date:  2007-09-11       Impact factor: 3.791

View more
  2 in total

Review 1.  The radiological diagnosis of pneumonia in children.

Authors:  Kerry-Ann F O'Grady; Paul J Torzillo; Kieran Frawley; Anne B Chang
Journal:  Pneumonia (Nathan)       Date:  2014-12-01

Review 2.  Community-acquired pneumonia among children: the latest evidence for an updated management.

Authors:  Cristiana M Nascimento-Carvalho
Journal:  J Pediatr (Rio J)       Date:  2019-09-10       Impact factor: 2.197

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.